ArticleWorld journal of surgical oncology2022

Loss of NPM2 expression is a potential immunohistochemical marker for malignant peritoneal mesothelioma: a single-center study of 92 cases.

He-Liang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.